Jane Street
CLBT icon

Jane Street’s Cellebrite CLBT Stock Holding History

Jane Street’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-714,514
Closed -$9.44M – 11706
2026
Q1 		$9.85M Buy
714,514
+474,991
+198% +$7.16M ﹤0.01% 2562
2025
Q4 		$4.32M Buy
+239,523
New +$4.3M ﹤0.01% 3460
2025
Q3 		– Sell
-79,506
Closed -$1.25M – 10860
2025
Q2 		$1.27M Buy
+79,506
New +$1.42M ﹤0.01% 5179
2025
Q1 		– Sell
-16,535
Closed -$364K – 9549
2024
Q4 		$364K Sell
16,535
-95,240
-85% -$1.83M ﹤0.01% 7402
2024
Q3 		$1.88M Buy
111,775
+14,288
+15% +$212K ﹤0.01% 4603
2024
Q2 		$1.16M Buy
97,487
+44,868
+85% +$501K ﹤0.01% 5488
2024
Q1 		$583K Buy
+52,619
New +$537K ﹤0.01% 6387

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street's CLBT Position: Q2 2026 in Review

Jane Street sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 714,514 shares — an estimated $9.44M sold.

Jane Street first reported a position in CLBT in Q1 2024 and held it in 7 quarters. The position peaked at $9.85M in Q1 2026. 186 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Jane Street reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 714,514 Cellebrite shares in Q2 2026, an estimated $9.44M.
  • Jane Street first reported a position in Cellebrite in Q1 2024 and held it in 7 quarters.
  • Jane Street's Cellebrite position peaked at $9.85M in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.